Andre Goy Selected Research

PRO131921 monoclonal antibody

9/2014

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andre Goy Research Topics

Disease

38	Neoplasms (Cancer) 01/2022 - 06/2003
33	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2022 - 06/2004
22	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2022 - 03/2003
19	Lymphoma (Lymphomas) 10/2022 - 03/2003
18	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 09/2003
12	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 02/2005
11	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 07/2003
10	B-Cell Lymphoma (Lymphoma, B Cell) 10/2022 - 03/2003
10	Disease Progression 01/2022 - 11/2011
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 03/2003
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2004
4	Ovarian Neoplasms (Ovarian Cancer) 03/2016 - 11/2010
3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2016 - 04/2013
3	Multiple Myeloma 10/2015 - 09/2012
2	Fever (Fevers) 01/2022 - 01/2018
2	COVID-19 01/2021 - 01/2020
2	Body Weight (Weight, Body) 01/2020 - 12/2017
2	Tumor Lysis Syndrome 01/2019 - 01/2018
2	Leukemia 01/2019 - 12/2017
2	Fatigue 01/2018 - 11/2017
2	Cough 11/2017 - 10/2015
2	Neutropenia 02/2016 - 03/2006
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2013 - 03/2011
2	Exanthema (Rash) 11/2011 - 08/2006
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 05/2004 - 06/2003
1	Cytokine Release Syndrome 10/2022
1	Residual Neoplasm 06/2022
1	Inflammation (Inflammations) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Chromosome Deletion (Deletion, Chromosome) 01/2019
1	Breast Neoplasms (Breast Cancer) 06/2018

Drug/Important Bio-Agent (IBA)

25	Rituximab (Mabthera)FDA Link 06/2022 - 07/2003
19	ibrutinibIBA 06/2022 - 08/2013
11	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2006
10	Bortezomib (Velcade)FDA Link 01/2018 - 03/2004
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2003
8	Chimeric Antigen ReceptorsIBA 10/2022 - 02/2015
8	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 08/2013
8	Proteins (Proteins, Gene)FDA Link 06/2018 - 03/2003
8	Lenalidomide (CC 5013)FDA Link 11/2017 - 11/2011
7	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 09/2003
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 09/2003
7	Pharmaceutical PreparationsIBA 07/2016 - 08/2006
6	Bendamustine Hydrochloride FDA Link 01/2022 - 12/2014
6	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 09/2003
5	axicabtagene ciloleucelIBA 10/2022 - 12/2017
5	venetoclaxIBA 06/2022 - 01/2018
5	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 06/2004
4	selinexorIBA 01/2022 - 07/2020
4	acalabrutinibIBA 11/2021 - 01/2018
4	Immunoconjugates (Immunoconjugate)IBA 03/2017 - 08/2013
4	denileukin diftitox (Ontak)FDA Link 07/2013 - 10/2004
4	Proteasome InhibitorsIBA 09/2012 - 03/2004
3	Biological ProductsIBA 01/2022 - 08/2009
3	Messenger RNA (mRNA)IBA 06/2018 - 12/2014
3	Brentuximab VedotinIBA 10/2016 - 08/2013
3	Prednisone (Sone)FDA LinkGeneric 12/2013 - 07/2013
2	brexucabtagene autoleucelIBA 06/2022 - 01/2020
2	AntibodiesIBA 01/2022 - 04/2004
2	Monoclonal AntibodiesIBA 01/2019 - 10/2015
2	Phosphotransferases (Kinase)IBA 01/2018 - 11/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 12/2013
2	obinutuzumabIBA 01/2017 - 10/2015
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2016 - 08/2013
2	Serine Proteases (Serine Protease)IBA 03/2016 - 12/2014
2	Syndecan-1 (Syndecan 1)IBA 10/2015 - 08/2013
2	Etoposide (VP 16)FDA LinkGeneric 07/2014 - 09/2003
2	Ifosfamide FDA LinkGeneric 07/2014 - 09/2003
2	Vinblastine (Vinblastine Sulfate)FDA Link 05/2012 - 11/2006
2	Dacarbazine (DIC)FDA LinkGeneric 05/2012 - 11/2006
2	Bleomycin (Blenoxane)FDA LinkGeneric 05/2012 - 11/2006
2	ibritumomab tiuxetan (Zevalin)FDA Link 02/2012 - 04/2004
2	pegfilgrastim (Neulasta)FDA Link 11/2006 - 03/2006
2	Anaplastic Lymphoma KinaseIBA 05/2004 - 06/2003
1	vistusertibIBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	Therapeutic UsesIBA 01/2021
1	CD19 AntigensIBA 01/2021
1	ChromatinIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	durvalumabIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	AnthracyclinesIBA 01/2019
1	ProlactinIBA 06/2018
1	Hormones (Hormone)IBA 06/2018
1	Androgen Receptors (Androgen Receptor)IBA 06/2018
1	Allopurinol (Remid)FDA LinkGeneric 01/2018
1	Saline SolutionIBA 01/2018
1	rasburicase (Elitek)FDA Link 01/2018

Therapy/Procedure

34	Therapeutics 01/2022 - 03/2004
17	Drug Therapy (Chemotherapy) 01/2020 - 09/2003
7	Stem Cell Transplantation 07/2020 - 07/2010
3	Precision Medicine 04/2017 - 10/2015
3	Aftercare (After-Treatment) 07/2012 - 10/2005
2	Salvage Therapy 01/2019 - 01/2017
1	Retreatment 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Drug Tapering 01/2018